Enprostil

DB13824ExperimentalSmall molecule

Enprostil: Overview.

Mechanism: Pharmacologically active on Prostaglandin E2 receptor EP1 subtype and Prostaglandin E2 receptor EP3 subtype
Curator reviewed
Formula / weight: C₂₃H₂₈O₆ · 400.471 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyPTOJVMZPWPAXER-FPXSIRDUSA-NSMILESCOC(=O)CCC=C=CC[C@H]1[C@H](\C=C\[C@H](O)COC2=CC=CC=C2)[C@@H](O)CC1=O

Targets

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

106Drug interactionsStructured to mechanism, not free text

1ATC codeIncluding every combination product, plus 15 drug categories

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Enprostil, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.